title: Clinical experience with endothelin receptor antagonists in chronic heart failure.
abstract: Both ET(A) selective and dual, ET(A/B), receptor antagonists have favourable short- and longer-term haemodynamic actions in patients with acute and chronic heart failure. Their effect on neurohumoral measures is not yet fully determined. Two moderately large, medium-duration studies have examined the effect of dual ET(A/B) receptor antagonists on clinical status, reaching conflicting conclusions. One large scale, long-term, morbidity mortality evaluation is underway with bosentan.
authors.affiliation: CRI in Heart Failure, Wolfson Building, University of Glasgow, Glasgow G12 8QQ.
authors.forename: A
authors.initials: A
authors.lastname: Seed
authors.forename: M P
authors.initials: MP
authors.lastname: Love
authors.forename: J J
authors.initials: JJ
authors.lastname: McMurray
mesh_terms: D002908:Chronic Disease; D002986:Clinical Trials as Topic; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000502:physiology; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008875:Middle Aged; D017466:Receptors, Endothelin / Q000502:physiology
chemical_list: D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D017466:Receptors, Endothelin